AdaptHealth Corp. $AHCO Shares Sold by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc lessened its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 16.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 41,127 shares of the company’s stock after selling 8,100 shares during the period. Ensign Peak Advisors Inc’s holdings in AdaptHealth were worth $388,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. AlphaQuest LLC raised its stake in shares of AdaptHealth by 275.7% during the second quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock worth $37,000 after purchasing an additional 2,892 shares during the last quarter. Assetmark Inc. raised its position in AdaptHealth by 87.6% during the 2nd quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock worth $52,000 after buying an additional 2,581 shares during the last quarter. Brooklyn Investment Group lifted its stake in shares of AdaptHealth by 531.8% in the 1st quarter. Brooklyn Investment Group now owns 7,563 shares of the company’s stock worth $82,000 after acquiring an additional 6,366 shares during the period. GAMMA Investing LLC boosted its holdings in shares of AdaptHealth by 38.7% in the second quarter. GAMMA Investing LLC now owns 10,365 shares of the company’s stock valued at $98,000 after acquiring an additional 2,892 shares in the last quarter. Finally, CWM LLC increased its stake in shares of AdaptHealth by 1,562.1% during the second quarter. CWM LLC now owns 10,471 shares of the company’s stock worth $99,000 after acquiring an additional 9,841 shares during the period. 82.67% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Canaccord Genuity Group raised their price objective on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Zacks Research downgraded AdaptHealth from a “hold” rating to a “strong sell” rating in a research report on Friday, September 19th. Wall Street Zen downgraded AdaptHealth from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 8th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of AdaptHealth in a report on Wednesday. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $13.60.

AdaptHealth Price Performance

AHCO opened at $9.65 on Monday. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 17.55, a price-to-earnings-growth ratio of 1.42 and a beta of 1.77. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.63. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.09. The company’s 50-day moving average price is $9.26 and its 200 day moving average price is $9.19.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.05). AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The business had revenue of $820.31 million for the quarter, compared to analyst estimates of $799.62 million. During the same quarter in the prior year, the firm posted $0.15 earnings per share. The business’s quarterly revenue was up 1.8% on a year-over-year basis. AdaptHealth has set its FY 2025 guidance at EPS. As a group, sell-side analysts expect that AdaptHealth Corp. will post 0.88 earnings per share for the current year.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.